StonvexLoading…
StonvexStonvexStonvexCore line items from C's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $85.22B | $80.72B | $78.07B | $75.34B |
Operating Income | $19.83B | $17.05B | $12.91B | $18.81B |
Net Income | $14.31B | $12.68B | $9.23B | $14.85B |
EPS (Diluted) | $6.99 | $5.94 | $4.04 | $7.00 |
Total Assets | $2.66T | $2.35T | $2.41T | $2.42T |
Total Liabilities | $2.44T | $2.14T | $2.21T | $2.21T |
Cash & Equivalents | $349.58B | $276.53B | $260.93B | $342.02B |
Free Cash Flow OCF − CapEx | $-74.15B | $-26.17B | $-80.00B | $19.44B |
Shares Outstanding | 1.87B | 1.94B | 1.96B | 1.96B |